Chemistry
Heterocyclic Compound
100%
Bioactivity
48%
Pyridine Ring
44%
Pyridone
44%
Molecular Model
44%
3,6-Dihydropyridine
33%
Deoxyribonucleic Acid
33%
RNA
33%
1,6-naphthyridine
33%
Microwave Irradiation
27%
Tyrosine Kinase Inhibitor
22%
Antioxidant Agent
22%
Hepatotoxic
22%
Epidermal Growth Factor
22%
Molecular Dynamics
22%
Enyne Metathesis
22%
Acrylate
22%
Pyrazole
22%
Erlotinib
22%
Single Bond
22%
Double Bond
22%
Non Toxic
22%
Naphthyridine
22%
Gefitinib
22%
Cholinesterase Inhibitor
22%
Base
22%
Paraquat
22%
EC50
22%
Sofosbuvir
22%
Acrylic Acid
22%
Guanidine
22%
Malononitrile
14%
Crystal Structure
11%
Propene
11%
Molecular Design
11%
Virtual Screening
11%
Cross-Coupling Reaction
11%
Antitumor
11%
Cyclohexanone
11%
Phenylhydrazine
11%
Diels-Alder Cycloaddition
11%
IC50
11%
Quaternization
11%
Tacrine
11%
Huperzine A
11%
Condensation
11%
Carbene
11%
Enyne
11%
Ring Closing Metathesis
11%
Anthracene
11%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
55%
EC50
51%
Pyrimidine Derivative
33%
Cyclam
29%
Naphthyridine Derivative
29%
Dihydropyridine
29%
Drug Discovery
27%
Phosphotransferase Inhibitor
26%
Protein Tyrosine Kinase Inhibitor
24%
Plerixafor
24%
Nonhodgkin Lymphoma
22%
B Lymphocyte Receptor
22%
Alzheimer's Disease
22%
Lymphoma
22%
Epidermal Growth Factor Receptor Kinase Inhibitor
22%
Cholinesterase Inhibitor
22%
Epidermal Growth Factor Receptor
22%
Lung Cancer
22%
Anaplastic Lymphoma Kinase
22%
Nucleoside
22%
Chemokine Receptor
22%
Alpha Chemokine
22%
Receptor
22%
Pharmacokinetics
22%
Biological Activity
20%
Janus Kinase 1
16%
Protein Tyrosine Kinase
15%
Cyanide
14%
Non Small Cell Lung Cancer
13%
Antiproliferative Activity
13%
Cell Culture
12%
Carbene
12%
Neoplasm
11%
Combinatorial Library
11%
Pyrimidine
11%
Metamizole
11%
Heterocyclic Compound
11%
Double Bond
11%
Single Bond
11%
Diffuse Large B Cell Lymphoma
11%
Clinical Trial
7%
Hepatotoxicity
7%
Cyclohexanone
7%
1 [(2 Hydroxyethoxy)methyl] 6 (Phenylthio)thymine
7%
Absorption-Distribution-Metabolism-Excretion Toxicity
7%
Huperzine A
7%
Anti-Human Immunodeficiency Virus
7%
Tacrine
7%
Liver Cell Carcinoma
7%
Antiviral Activity
7%
Medicine and Dentistry
Non Small Cell Lung Cancer
35%
Phosphotransferase Inhibitor
26%
B Lymphocyte Receptor
22%
Antineoplastic Activity
22%
Lymphoma
22%
Epidermal Growth Factor Receptor
22%
STAT3 Protein
22%
Synapsin I
22%
Treatment of Lung Cancer
22%
Anaplastic Lymphoma Kinase
22%
Chemokine Receptor
22%
Alpha Chemokine
22%
Molecular Model
22%
Janus Kinase 1
16%
Protein Tyrosine Kinase
15%
Neoplasm
13%
Epidermal Growth Factor Receptor Kinase Inhibitor
13%
Antiproliferative Activity
13%
Non-Hodgkin Lymphoma
11%
B Cell
11%
Non-Hodgkin Lymphoma Cell Line
11%
Signal Transduction
11%
Diffuse Large B-Cell Lymphoma
11%
In Vitro
5%
Hazard Ratio
5%
Lung Cancer Cell Line
5%
Treatment Response
5%
Lung Cancer
5%
Real-Time Polymerase Chain Reaction
5%
Docking (Molecular)
5%
Virtual Screening
5%
IC50
5%
Plerixafor
5%